Elevate Total Current Liabilities vs Total Revenue Analysis

EL8 Stock   0.30  0.02  7.14%   
Elevate Uranium financial indicator trend analysis is much more than just examining Elevate Uranium latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Elevate Uranium is a good investment. Please check the relationship between Elevate Uranium Total Current Liabilities and its Total Revenue accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevate Uranium. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Current Liabilities vs Total Revenue

Total Current Liabilities vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Elevate Uranium Total Current Liabilities account and Total Revenue. At this time, the significance of the direction appears to have strong relationship.
The correlation between Elevate Uranium's Total Current Liabilities and Total Revenue is 0.72. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Elevate Uranium, assuming nothing else is changed. The correlation between historical values of Elevate Uranium's Total Current Liabilities and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Elevate Uranium are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Total Current Liabilities i.e., Elevate Uranium's Total Current Liabilities and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.72
Relationship DirectionPositive 
Relationship StrengthSignificant

Total Current Liabilities

Total Current Liabilities is an item on Elevate Uranium balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Elevate Uranium are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Revenue

Total revenue comprises all receipts Elevate Uranium generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.
Most indicators from Elevate Uranium's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Elevate Uranium current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevate Uranium. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Selling General Administrative is likely to gain to about 4.3 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 258.8 K in 2024.
 2021 2022 2023 2024 (projected)
Interest Income6.6K27.0K24.3K23.1K
Cost Of Revenue85.5K117.7K121.7K115.6K

Elevate Uranium fundamental ratios Correlations

0.260.590.990.86-0.99-0.690.990.860.990.15-0.390.990.840.570.330.220.940.52-0.49-0.63-0.23-0.1-0.69-0.49-0.49
0.260.450.220.2-0.25-0.340.270.190.27-0.140.270.260.32-0.080.310.210.230.5-0.280.04-0.360.49-0.070.160.16
0.590.450.530.39-0.58-0.780.620.380.620.050.140.620.770.830.520.520.720.54-0.44-0.24-0.350.29-0.36-0.76-0.76
0.990.220.530.88-0.99-0.650.970.880.970.21-0.490.970.80.540.250.150.930.51-0.46-0.71-0.16-0.15-0.76-0.46-0.46
0.860.20.390.88-0.82-0.590.781.00.780.08-0.560.780.730.380.280.110.830.58-0.51-0.72-0.22-0.17-0.78-0.33-0.33
-0.99-0.25-0.58-0.99-0.820.66-0.99-0.82-0.99-0.210.43-0.99-0.81-0.57-0.26-0.18-0.94-0.490.450.670.160.120.720.480.48
-0.69-0.34-0.78-0.65-0.590.66-0.69-0.57-0.69-0.23-0.04-0.69-0.97-0.71-0.84-0.79-0.81-0.80.820.290.740.020.440.570.57
0.990.270.620.970.78-0.99-0.690.781.00.15-0.311.00.830.590.330.250.920.48-0.47-0.57-0.22-0.07-0.63-0.51-0.51
0.860.190.380.881.0-0.82-0.570.780.780.08-0.580.780.710.370.250.090.820.56-0.48-0.74-0.19-0.18-0.79-0.33-0.33
0.990.270.620.970.78-0.99-0.691.00.780.15-0.311.00.830.590.330.250.920.48-0.47-0.57-0.22-0.07-0.63-0.51-0.51
0.15-0.140.050.210.08-0.21-0.230.150.080.15-0.520.170.250.190.10.050.270.25-0.21-0.52-0.05-0.35-0.54-0.21-0.21
-0.390.270.14-0.49-0.560.43-0.04-0.31-0.58-0.31-0.52-0.32-0.13-0.080.390.5-0.42-0.15-0.040.92-0.430.460.850.120.12
0.990.260.620.970.78-0.99-0.691.00.781.00.17-0.320.830.590.330.250.920.48-0.47-0.57-0.22-0.07-0.64-0.51-0.51
0.840.320.770.80.73-0.81-0.970.830.710.830.25-0.130.830.720.730.650.910.78-0.77-0.45-0.62-0.06-0.58-0.62-0.62
0.57-0.080.830.540.38-0.57-0.710.590.370.590.19-0.080.590.720.390.460.740.35-0.32-0.39-0.17-0.15-0.44-0.91-0.91
0.330.310.520.250.28-0.26-0.840.330.250.330.10.390.330.730.390.930.40.71-0.860.16-0.970.11-0.01-0.34-0.34
0.220.210.520.150.11-0.18-0.790.250.090.250.050.50.250.650.460.930.330.55-0.770.28-0.90.110.12-0.33-0.33
0.940.230.720.930.83-0.94-0.810.920.820.920.27-0.420.920.910.740.40.330.63-0.54-0.7-0.26-0.16-0.78-0.63-0.63
0.520.50.540.510.58-0.49-0.80.480.560.480.25-0.150.480.780.350.710.550.63-0.86-0.38-0.680.06-0.54-0.27-0.27
-0.49-0.28-0.44-0.46-0.510.450.82-0.47-0.48-0.47-0.21-0.04-0.47-0.77-0.32-0.86-0.77-0.54-0.860.150.85-0.130.320.240.24
-0.630.04-0.24-0.71-0.720.670.29-0.57-0.74-0.57-0.520.92-0.57-0.45-0.390.160.28-0.7-0.380.15-0.260.380.980.350.35
-0.23-0.36-0.35-0.16-0.220.160.74-0.22-0.19-0.22-0.05-0.43-0.22-0.62-0.17-0.97-0.9-0.26-0.680.85-0.26-0.15-0.080.110.11
-0.10.490.29-0.15-0.170.120.02-0.07-0.18-0.07-0.350.46-0.07-0.06-0.150.110.11-0.160.06-0.130.38-0.150.270.140.14
-0.69-0.07-0.36-0.76-0.780.720.44-0.63-0.79-0.63-0.540.85-0.64-0.58-0.44-0.010.12-0.78-0.540.320.98-0.080.270.380.38
-0.490.16-0.76-0.46-0.330.480.57-0.51-0.33-0.51-0.210.12-0.51-0.62-0.91-0.34-0.33-0.63-0.270.240.350.110.140.381.0
-0.490.16-0.76-0.46-0.330.480.57-0.51-0.33-0.51-0.210.12-0.51-0.62-0.91-0.34-0.33-0.63-0.270.240.350.110.140.381.0
Click cells to compare fundamentals

Elevate Uranium Account Relationship Matchups

Elevate Uranium fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets4.4M10.0M19.3M12.5M13.3M13.9M
Other Current Liab283.8K188.8K566.5K487.9K300.4K157.7K
Total Current Liabilities353.8K337.0K675.5K948.5K1.4M1.5M
Total Stockholder Equity3.9M9.5M18.5M11.5M11.8M12.4M
Property Plant And Equipment Net3.2M3.3M3.4M2.4M2.3M2.5M
Net Debt(997.7K)(6.6M)(15.6M)(9.9M)(10.8M)(10.2M)
Retained Earnings(52.5M)(54.9M)(60.6M)(70.1M)(80.8M)(76.8M)
Cash1.1M6.7M15.8M10.1M10.8M11.4M
Non Current Assets Total3.2M3.3M3.4M2.4M2.3M2.5M
Cash And Short Term Investments1.1M6.7M15.8M10.1M10.8M11.4M
Net Receivables65.9K31.2K84.2K83.1K87.0K115.6K
Liabilities And Stockholders Equity4.4M10.0M19.3M12.5M13.3M13.9M
Total Liab435.0K429.5K838.6K1.0M1.5M949.0K
Total Current Assets1.1M6.7M15.9M10.1M10.9M11.5M
Accumulated Other Comprehensive Income485.2K371.8K1.1M3.4M4.6M4.9M
Common Stock55.9M64.0M78.0M78.2M88.0M92.4M
Accounts Payable47.3K98.1K39.0K387.0K870.7K914.2K
Other Stockholder Equity(1.1M)(1.6M)(1.7M)613.3K705.3K740.6K
Common Stock Shares Outstanding103.3M180.5M252.1M275.5M294.8M309.5M
Inventory(65.91)(31.21)(84.21)(83.12)(95.59)(100.37)
Other Current Assets65.9131.2184.2183.1274.8171.07
Short Term Debt22.7K50.2K70.0K73.6K33.5K31.8K
Non Current Liabilities Total81.2K92.5K163.1K72.4K40.8K38.7K
Property Plant Equipment3.2M3.3M3.4M2.4M2.8M1.7M
Long Term Debt Total42.5K49.1K107.2K72.4K65.2K61.9K
Cash And Equivalents1.1M6.7M15.8M10.1M11.6M12.1M
Net Tangible Assets3.9M9.5M18.5M11.5M13.2M7.8M
Net Invested Capital3.9M9.5M18.5M11.5M13.2M8.2M
Net Working Capital775.1K6.4M15.2M9.2M10.6M6.0M
Capital Stock55.9M64.0M78.0M78.2M89.9M72.0M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Elevate Stock Analysis

When running Elevate Uranium's price analysis, check to measure Elevate Uranium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevate Uranium is operating at the current time. Most of Elevate Uranium's value examination focuses on studying past and present price action to predict the probability of Elevate Uranium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevate Uranium's price. Additionally, you may evaluate how the addition of Elevate Uranium to your portfolios can decrease your overall portfolio volatility.